Liverpool Launches Infectious Diseases Research Centre

The University of Liverpool and Liverpool School of Tropical Medicine (LSTM) have launched a new joint centre that aims to address the urgent need to develop new antimicrobials and accelerate solutions for existing and emerging infections.

The Centre of Excellence in Infectious Diseases Research (CEIDR) will work with the NHS and industry to capitalise on the expertise and research within the institutions, allowing partners to simplify the R&D processes and reduce time and cost in order to accelerate new products into the marketplace.

Professor Bob Burgoyne Executive Pro-Vice-Chancellor for Health and Life Sciences at the University of Liverpool, along with LSTM’s Director, Professor Janet Hemingway welcomed partners and invited guests to the launch event at LSTM and introduced them to CEIDR’s vision to address some of the most significant challenges in global healthcare today.

Professor Burgoyne, said: “Liverpool’s infection research is unique in the UK bringing together the co-location of veterinary, medicine and tropical medicine along with a focus on later stage R&D and one of the highest densities of Cat III facilities in the UK.

“Along with our partners we can provide access to world-class facilities, know-how and funding for those looking to develop products for the diagnosis, prevention or treatment of infectious diseases.”

The centre will utilise space in the new £24m Liverpool Life Sciences Accelerator building, due to be opened later this year and will stand within The Knowledge Quarter Liverpool, home to some of the world’s most influential players in science, health, technology, culture and education.